From early development to market access and beyond, we deliver integrated advice and evidence driven solutions that help innovative medicines and vaccines achieve sustainable access and better health outcomes.
Learn More About Us Contact UsA unique fusion of public health leadership and market access expertise.
Over 23 years of experience in infectious diseases, vaccines, market access and health policy.
✓ Former Director of Market Access & Policy Affairs, Moderna UK & Ireland
✓ Previous Senior Leadership roles at SPMSD, Sanofi and Biogen
✓ Former Senior Expert Adviser, UK Government
✓ Author of 180+ peer reviewed papers
✓ Honorary Assistant Professor at University of Nottingham
Internationally recognised leader in public health, respiratory viruses and pandemic response.
✓ Former Deputy Chief Medical Officer for England (2017-2022)
✓ Knighted in 2022 for services to public health
✓ Extensive academic and government experience
✓ Trusted adviser on vaccines, pandemic preparedness and health strategy
CVT Market Access Solutions Ltd creates a fusion of Stuart Carroll’s two decades of experience across vaccines, infectious diseases, market access and public health policy, with Jonathan Van-Tam’s lifetime of medical and public health policy expertise. This creates a unique offering for clients, especially pharmaceutical companies seeking to navigate complex healthcare ecosystems and policy landscapes to secure sustainable access for innovative medicines and vaccines. The firm combines expertise in market access strategy, health economics and outcomes research (HEOR), pricing and reimbursement, medical affairs, and government policy with deep experience in public health and health technology assessment.
CVT advisors work at the intersection of science, medicine, policy and healthcare systems, to provide strategic support and advice across the full product lifecycle, from early evidence generation and access strategy through to policy engagement, reimbursement negotiations and stakeholder communications.
Market Access and
Strategy
HEOR & Evidence Generation
Pricing &
Reimbursement
Medical Affairs &
Policy
Government &
Health Policy
Medical Affairs & Scientific Strategy
We are an advisory firm not an agency; our support to you comes in the form of written and spoken advice, alongside detailed review of your company’s propositions and strategies, as required.
We are not a delivery partner who provides services, as agencies typically do.
We work alongside clients and inside their organisations, but we don’t ‘front’ outsourced activities on behalf of clients.
We are currently a ‘two-person band’: we have no junior staff to whom we can delegate.
Our clients get direct access to the two named experts who are the co-owners and founders of CVT.
Our clients ultimately choose the weighting of the ‘work effort’ they wish to receive from the two CVT advisors.
We only accept assignments where we feel satisfied that: a) we can make a meaningful contribution; and b) the sum of our combined contributions is likely to be greater than its constituent separate parts
We are not ‘yes people’; we will always give honest and realistic advice to our clients, even when we think it may be hard to hear.
We realise we are only as good as our current or recent reputation and obsess about feedback and client satisfaction.
On 8th September, 24 delegates from across multiple companies attended our first ever workshop on Understanding and Interacting with JCVI, held in central London. We think it went very well, but here's what a few of the delegates said to us afterwards:
Even though I have many years of working with the JCVI and benefit from established contacts, this course explained aspects and nuances that I had not previously considered and in that regard was extremely useful. In addition, the session on health economics was excellent and linked seamlessly to the JCVI component. Highly recommended for those new to the industry and also more experienced people.
- Senior Medical Adviser
I recently had the pleasure of attending an all-day workshop co-hosted by Stuart and JVT on vaccines reimbursement. The insights and clarity provided by then both were invaluable, and it was one of the most informative (as well as enjoyable) learning days I have had in a long time.
- Senior Medic
The course did an excellent job of simplifying what can be quite complex systems and processes. Both presenters made the JCVI pathway clear, practical and easy to understand, meaning that even those of us in the room without previous experience came away feeling far more knowledgeable and confident in how the process works.
- General Manager
Quite a few attendees said afterwards, they felt that more of their colleagues might benefit from the same experience. Others wanted to attend but simply couldn't accommodate our chosen date.
Therefore, we'll be running it again in Spring 2027. We don't yet know when or where, but when we do, we'll update this section of the website (please visit our website again in early 2027). If you'd like to leave some details here, we will place you on a *priority list for the next course. There's absolutely *no obligation if you do this. But it means we can contact you as soon as we have a date and venue and at that point we'll give you priority booking for the next 7 days.
Be the first to know when we are running the next course. Complete the form below and we will be in touch as soon as we have a date and venue.
* The priority list will not have more slots than we have places available in total, likely to be 25 again to retain a good dynamic interaction. If the list gets full, we will not accept further names, so that no-one on it is disappointed. We can provide a similar course on a single company, exclusive and private, basis for up 12 employees. Contact us via a General Inquiry if that is of interest.
We would love to hear from you.
Please fill out the form and we will be in contact.
All fields are mandatory.